COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,741 Articles (22,502 medRxiv, 8,239 bioRxiv)

Most recent first Previous |  Page 1238: Articles 12371-12380  | Next

Model-based assessment of SARS-CoV-2 Delta variant transmission dynamics within partially vaccinated K-12 school populations
Head, J. R., Andrejko, K. L., Remais, J. V.
10.1101/2021.08.20.21262389 — Posted: 2021-08-23
The impact on the mental health and well-being of unpaid carers affected by social distancing, self-isolation and shielding during the COVID 19 pandemic in England - a systematic review
Akafekwa, T., Dalgarno, E., Verma, A.
10.1101/2021.08.20.21262375 — Posted: 2021-08-23
Pediatric critical COVID-19 and mortality in a multinational cohort
Gonzalez-Dambrauskas, S., Vasquez-Hoyos, P., Camporesi, A., Cantillano, E. M., Dallefeld, S., Dominguez-Rojas, J., Francoeur, C., Gurbanov, A., Mazzillo-Vega, L., Shein, S., Yock-Corrales, A., Karsies, T., Critical Coronavirus and Kids Epidemiological (CAKE) Study Investigators
10.1101/2021.08.20.21262122 — Posted: 2021-08-23
Immunological Insights Into the Therapeutic Roles of CD24Fc Against Severe COVID-19
Song, N.-J., Allen, C., Vilgelm, A. E., Riesenberg, B. P., Weller, K. P., Reynolds, K., Chakravarthy, K. B., Kumar, A., Khatiwada, A., Sun, Z., Ma, A., Chang, Y., Yusuf, M., Li, A., Zeng, C., Evans, J. P., Bucci, D., Gunasena, M., Xu, M., Liyanage, N. P. M., Bolyard, C., Velegraki, M., Liu, S.-L., Ma, Q., Devenport, M., Liu, Y., Zheng, P., Malvestutto, C. D., Chung, D., Li, Z.
10.1101/2021.08.18.21262258 — Posted: 2021-08-23 Discussion: Onsite
Predicting SARS-CoV-2 infections for children and youth with single symptom screening
Webster, R. J., Reddy, D., Harrison, M.-A., Farion, K. J., Willmore, J., Foote, M., Thampi, N.
10.1101/2021.08.19.21262310 — Posted: 2021-08-23
Effects of face masks and ventilation on the risk of SARS-CoV-2 respiratory transmission in public toilets: a quantitative microbial risk assessment
Denpetkul, T., Sittipunsakda, O., Pumkaew, M., Mongkolsuk, S., sirikanchana, k.
10.1101/2021.08.21.457245 — Posted: 2021-08-22 Discussion: Onsite
Delta variant and mRNA Covid-19 vaccines effectiveness: higher odds of vaccine infection breakthroughs
Kislaya, I., Rodrigues, E. F., Borges, V., Gomes, J. P., Sousa, C., Almeida, J. P., Peralta-Santos, A., Nunes, B., PT-Covid-19 Group
10.1101/2021.08.14.21262020 — Posted: 2021-08-22 Discussion: Offsite
Anticipating the hospital burden of future COVID-19 epidemic waves
Boennec, C., Alizon, S., Sofonea, M. T.
10.1101/2021.08.19.21262280 — Posted: 2021-08-22
CORONAVIRUS DISEASE 2019 IN A TERTIARY PEDIATRIC CENTER IN PORTUGAL
Milheiro Silva, T., Garcia, A. M., Gouveia, C., Candeias, F., Brito, M. J.
10.1101/2021.08.16.21262100 — Posted: 2021-08-22
Modeling SARS-CoV-2 transmission at a winter destination resort region with high outside visitation
Wu, E. J., Bayham, J., Carlton, E. J., Samet, J. M., Buchwald, A. G.
10.1101/2021.08.18.21262227 — Posted: 2021-08-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).